Chemotherapy Communication Pharmacy Technician 
Pharmacy Times
JUNE 11, 2025
The findings highlight that there remain communication gaps between oncology providers and patients and that opportunities exist for pharmacists to counsel newly diagnosed oncology patients on their fertility preservation options.
Pharmacy Times
JUNE 17, 2025
If a discrepancy is found, the pharmacy nurses will hold the shipment, and a clinical intervention will be communicated to the provider. Results American Oncology Network (AON) Pharmacy collected data on waste and cost avoidance from February 2023 to September 2023.
This site is protected by reCAPTCHA and the Google Privacy Policy and Terms of Service apply.
Pharmacy Times
JUNE 20, 2025
These job duties each require different skill sets, from writing and verbal communication to process development, technical aptitude, and deep clinical expertise. Someone adept at all these skills simultaneously is called a unicorn—and unicorns are rare in oncology pharmacy, if they exist at all.
Pharmacy Times
JULY 9, 2025
High doses of steroids, whether administered before or during treatment with an immune checkpoint inhibitor (ICI), caused the tumors of patients with non-small cell lung cancer (NSCLC) to shrink less than those not on steroids, according to recent study results published by investigators in Cancer Research Communications.
Pharmacy Times
JULY 3, 2025
Pharmacy Times : How does the team ensure smooth transitions from inpatient to outpatient transplant care, particularly regarding medication management? Our next thing that we're looking at is how do we do allogeneic stem cell transplants in the outpatient setting? Again, I think that'll be a hybrid.
Pharmacy Times
JUNE 18, 2025
Mok : Right now, we have a lot of chemotherapy being used, but there are many more novel treatments being studied, especially in earlier lines of treatment. Bispecifics are moving up in the lymphoma space, and these newer therapies may have some synergistic effects with chemotherapy. REFERENCES 1.
Pharmacy Times
AUGUST 7, 2025
Methods Patients aged 18 to 59 years with t-AML or AML-MRC treated with CPX-351 or 7+3 as induction chemotherapy between 2015 and 2022 at 3 National Cancer Institute–designated cancer centers were included. Study Design Retrospective, multicenter, observational cohort study.
Expert insights. Personalized for you.
Let's personalize your content